- Home
- FDBC vs NVCT Comparison
FDBC vs NVCT Comparison
Compare FDBC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- NVCT
- Stock Information
- Founded
- FDBC 1902
- NVCT 2020
- Country
- FDBC United States
- NVCT United States
- Employees
- FDBC N/A
- NVCT N/A
- Industry
- FDBC Major Banks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- FDBC Finance
- NVCT Health Care
- Exchange
- FDBC Nasdaq
- NVCT Nasdaq
- Market Cap
- FDBC 226.2M
- NVCT 249.1M
- IPO Year
- FDBC N/A
- NVCT 2022
- Fundamental
- Price
- FDBC $40.34
- NVCT $8.99
- Analyst Decision
- FDBC
- NVCT Strong Buy
- Analyst Count
- FDBC 0
- NVCT 3
- Target Price
- FDBC N/A
- NVCT $17.00
- AVG Volume (30 Days)
- FDBC 6.4K
- NVCT 160.9K
- Earning Date
- FDBC 04-23-2025
- NVCT 05-06-2025
- Dividend Yield
- FDBC 3.97%
- NVCT N/A
- EPS Growth
- FDBC 32.67
- NVCT N/A
- EPS
- FDBC 3.75
- NVCT N/A
- Revenue
- FDBC $81,621,000.00
- NVCT N/A
- Revenue This Year
- FDBC N/A
- NVCT N/A
- Revenue Next Year
- FDBC N/A
- NVCT N/A
- P/E Ratio
- FDBC $10.76
- NVCT N/A
- Revenue Growth
- FDBC 15.50
- NVCT N/A
- 52 Week Low
- FDBC $37.00
- NVCT $4.44
- 52 Week High
- FDBC $61.21
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- FDBC 48.15
- NVCT 47.46
- Support Level
- FDBC $40.54
- NVCT $8.01
- Resistance Level
- FDBC $41.50
- NVCT $9.62
- Average True Range (ATR)
- FDBC 1.20
- NVCT 1.04
- MACD
- FDBC 0.29
- NVCT -0.16
- Stochastic Oscillator
- FDBC 50.09
- NVCT 27.96
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.